![](https://cdn.prod.website-files.com/63da4ae4359b4b2bffd2a3b6/6453da50b37b0cf2335f4195_article-hero.jpg)
Related articles
![Medable's analysis on DCT and digital trial elements](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/664d586790e2544d8ebfb8a3_evidence%20and%20insights%20book.jpg)
![](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/645acebd4c26031990557a26_ben-kolde-t9DooibgMEk-unsplash.jpg)
Evidence & Insights: A Data-Driven Exploration of Decentralized Elements and Digital Trial Technologies
In Medable’s first edition of Evidence and Insights, you’ll get an in-depth look at our research investments and collaborations exploring the effects of DCTs and clinical research technology. Through strategic partnerships and continued investment, we’ve spearheaded efforts that redefine industry standards and set a new precedent for the evidentiary basis of technology’s impact on drug development.
![JPM 2024 AI panel](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/645005e205aa34c15fd940cc_medable-back-to-basics-total-consent-dct-platforms.jpg)
![](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/64482e8f985430a5be0f547f_medable-man-reclining-reading-ipad-article-patient-centricity.jpg)
Experts discuss AI’s future in pharma
In June of 2022, Open AI forever changed the world’s technological landscape with the release of ChatGPT 3.5. The explosion and proliferation of AI tools have become a focal point of interest and curiosity in almost every industry, with commentators in pharma wondering how AI can improve clinical research.
In January 2024, panelists from Syneos, Obvious Ventures, Sapphire Ventures, IDEA Pharma, and GSR Ventures joined Medable’s CEO, Dr. Michelle Longmire, to discuss the purpose, potential, and power this transformative technology offers.
Here’s what they had to say.
![](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/64b948634ca8bdf05469ea9e_medable-woman-in-meeting-patient-centricity-clinical-trials.jpg)
![](https://cdn.prod.website-files.com/63f6c0d2675ee198a17d310a/64482e8f985430a5be0f547f_medable-man-reclining-reading-ipad-article-patient-centricity.jpg)
Rapid evolution: How DCT’s DNA became standard in modern clinical trials
It’s impossible to deny how different clinical trials look almost four years after the pandemic revolutionized clinical research. Today, the digital and decentralized tools and technologies that enabled clinical trials to carry on through the COVID-19 pandemic are present (in some form) in nearly all clinical trials, a far cry from the dynamics of 2019.